BNP PARIBAS FINANCIAL MARKETS - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,510
-78.9%
2,100
-80.6%
0.00%
Q2 2023$30,808
+263.5%
10,810
+402.6%
0.00%
Q1 2023$8,475
+42.7%
2,151
+43.4%
0.00%
Q4 2022$5,940
-100.0%
1,500
-61.0%
0.00%
Q1 2022$24,704,0003,8480.00%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Alta Fundamental Advisers LLC 1,176,189$3,646,1861.74%
Bleichroeder LP 1,326,085$4,110,8641.01%
BML Capital Management, LLC 272,500$844,7500.78%
VR Adviser, LLC 2,208,812$6,847,3170.72%
Lion Point Capital, LP 450,207$1,395,6420.62%
PVG ASSET MANAGEMENT CORP 15,405$47,7550.32%
Affinity Asset Advisors, LLC 335,068$1,038,7110.29%
RTW INVESTMENTS, LP 3,256,102$10,093,9160.21%
Ikarian Capital, LLC 462,828$1,434,7670.17%
Boxer Capital, LLC 309,007$957,9220.05%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders